The results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2024 October 23–27. Finerenone—a selective ...
Morning Overview on MSN
High Alzheimer’s biomarkers may point to kidney issues, not brain
Blood tests for Alzheimer’s disease are rapidly moving into clinics, promising earlier and easier detection of brain changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback